Viewing Study NCT02856568


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-01-04 @ 8:36 AM
Study NCT ID: NCT02856568
Status: WITHDRAWN
Last Update Posted: 2017-05-30
First Post: 2016-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module